Global Blood Plasma Derivatives Market Report 2024

Blood Plasma Derivatives Global Market Report 2025 – By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types), By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Blood Plasma Derivatives Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Blood Plasma Derivatives Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Blood Plasma Derivatives Market Definition

Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body.

The main types of blood plasma derivatives are albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. Albumin refers to an essential protein present in blood plasma derivatives that aids in the regulation of osmotic pressure within the blood and facilitates the transportation of hormones, metals, and other molecules throughout the body. These are used in several applications, such as hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand's disease, and others, which are used by various end-users, including hospitals, clinics, and others.

Blood Plasma Derivatives Market Segmentation

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Blood Plasma Derivatives Market Size and growth rate 2025 to 2029: Graph

Blood Plasma Derivatives Market Size 2025 And Growth Rate

The blood plasma derivatives market size has grown strongly in recent years. It will grow from $51.81 billion in 2024 to $56.24 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services

Blood Plasma Derivatives Market Growth Forecast

The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $80.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation.

Blood Plasma Derivatives Market Driver: Surging Demand For Blood Plasma Derivatives Driven By The Increasing Prevalence Of Immune Deficiency Disorders

The increasing prevalence of immunodeficiency disorders is expected to drive the growth of the blood plasma derivatives market. Immunodeficiency disorders are illnesses that either completely or partially compromise the immune system. Blood plasma derivatives find application in treating a multitude of medical conditions, including immune deficiency disorders. Plasma, a solution consisting of proteins and salts, encompasses over 100 different proteins, among which immunoglobulins are particularly utilized for addressing primary immunodeficiencies. Poor nutrition or malnutrition leads to macro- and micronutrient deficiencies, which can lead to immunodeficiency. For instance, in March 2022, according to the Allergy, Asthma & Clinical Immunology, the most common condition was Common Variable Immunodeficiency (CVID), affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% worldwide. Therefore, the increasing prevalence of immune deficiency disorders is driving the growth of the blood plasma derivatives market.

Blood Plasma Derivatives Market Driver: Impact Of Trauma And Accident Cases On The Surging Growth Of The Blood Plasma Derivatives Market

The rise in trauma and accident cases is expected to propel the growth of the blood plasma derivatives market going forward. Trauma and accident cases refer to situations where individuals experience physical injuries or harm as a result of an unexpected incident or event. Blood plasma derivatives are used in trauma and accident cases to replace clotting factors, treatment for hemorrhagic shock, to hemostasis and coagulation control, fluid replacement, wound healing support, and to manage edema and support fluid balance. For instance, in April 2024, according to the National Highway Traffic Safety Administration, a US-based government agency, in 2022, 3,308 people were killed and an estimated additional 289,310 people were injured in crashes involving distracted drivers. Therefore, the rise in trauma and accident cases is driving the growth of the blood plasma derivatives market.

Blood Plasma Derivatives Market Driver: Rising Hemophilia Prevalence Ignites Growth In The Blood Plasma Derivatives Market

The increasing prevalence of hemophilia is expected to drive the growth of the blood plasma derivatives market. Hemophilia refers to a bleeding problem that is hereditary and causes the blood to not clot properly. This may result in both spontaneous bleeding and bleeding after injury or surgery. In people with hereditary or acquired problems with hemostasis, blood plasma-derived products or medications can effectively improve hemostasis. Treatment for hemophilia A, von Willebrand disease, and hemophilia B uses factor VIII, factor VIII/vWF, and factor IX concentrates, respectively. For instance, in August 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, there were 3.7 cases of hemophilia B and 12 cases of hemophilia A per 100,000 American males in the country, respectively. Moreover, it affects 1 in 5,617 male births in the United States and 1 in 19,283 male births with hemophilia B. Therefore, the increasing prevalence of hemophilia is driving the growth of the blood plasma derivatives market.

Global Blood Plasma Derivatives Market Major Players

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Global Blood Plasma Derivatives Market Trend: Strategic Partnerships In The Blood Plasma Derivatives Market For Enhancing Access And Supply For Immunoglobulins In France And Beyond

Major companies operating in the blood plasma derivatives market are focused on adopting strategic partnerships to gain a competitive edge in the market. With this partnership, patients in need will have access to a steady and dependable supply of these vital plasma-derived medications, helping to meet the increasing need for immunoglobulins in France and beyond. For instance, in January 2022, Kedrion S.p.A. an Italy-based biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies partnered with LPB, a UK-based pharmaceutical company specializing in biological medicinal products. Kedrion will use LFB plasma obtained in France by the Etablissement Français du Sang (EFS) to produce immunoglobulins in Hungary. The current supply of immunoglobulins, which will be made available to hospitals across the nation in accordance with and under the supervision of French health authorities, will be supplemented by these imports from LFB in France.

Blood Plasma Derivatives Market Merger And Acquisition: Grifols S.A. Enhances Plasma Medicine Availability And Expands Product Line With Acquisition Of Biotest Ag

In April 2022, Grifols S.A., a Spain-based producer of plasma-derived medicines, acquired Biotest AG for an undisclosed amount. The acquisition of Biotest AG allows Grifols to improve the availability of plasma medicines for patients, accelerate and expand its product line, own the most extensive private European network of plasma facilities with 87 locations, and drive revenue growth and profitability expansion. Biotest AG is a Germany-based producer of several human blood plasma-derived concentrates for intensive care medicines.

Regional Outlook For The Global Blood Plasma Derivatives Market

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood plasma derivatives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Blood Plasma Derivatives Market?

The blood plasma derivatives market consists of sales of fibrinogen, globulin, sodium, potassium, bicarbonate, and chloride. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Blood Plasma Derivatives Industry?

The blood plasma derivatives market research report is one of a series of new reports from The Business Research Company that provides blood plasma derivatives market statistics, including blood plasma derivatives industry global market size, regional shares, competitors with a blood plasma derivatives market share, detailed blood plasma derivatives market segments, market trends and opportunities, and any further data you may need to thrive in the blood plasma derivatives industry. This blood plasma derivatives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Blood Plasma Derivatives Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $56.24 billion
Revenue Forecast In 2034 $80.42 billion
Growth Rate CAGR of 9.4% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users Subsegments: 1) By Albumin: Human Serum Albumin, Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin 6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Blood Plasma Derivatives Market Characteristics

    3. Blood Plasma Derivatives Market Trends And Strategies

    4. Blood Plasma Derivatives Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Blood Plasma Derivatives Growth Analysis And Strategic Analysis Framework

    5.1. Global Blood Plasma Derivatives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Blood Plasma Derivatives Market Growth Rate Analysis

    5.4. Global Blood Plasma Derivatives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Blood Plasma Derivatives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Blood Plasma Derivatives Total Addressable Market (TAM)

    6. Blood Plasma Derivatives Market Segmentation

    6.1. Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Albumin

    Factor VIII

    Factor IX

    Immunoglobulin

    Hyperimmune Globulin

    Other Types

    6.2. Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hemophilia

    Hypogammaglobulinemia

    Immunodeficiency Diseases

    Von Willebrand's Disease

    Other Applications

    6.3. Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Other End-Users

    6.4. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Human Serum Albumin

    Recombinant Albumin

    6.5. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Plasma-Derived Factor VIII

    Recombinant Factor VIII

    6.6. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Plasma-Derived Factor IX

    Recombinant Factor IX

    6.7. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Intravenous Immunoglobulin (IVIG)

    Subcutaneous Immunoglobulin (SCIG)

    6.8. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Specific Pathogen-Reduced Hyperimmune Globulin

    Standard Hyperimmune Globulin

    6.9. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Fibrinogen

    Clotting Factor Concentrates

    Plasma-Derived Proteins

    7. Blood Plasma Derivatives Market Regional And Country Analysis

    7.1. Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Blood Plasma Derivatives Market

    8.1. Asia-Pacific Blood Plasma Derivatives Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Blood Plasma Derivatives Market

    9.1. China Blood Plasma Derivatives Market Overview

    9.2. China Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Blood Plasma Derivatives Market

    10.1. India Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Blood Plasma Derivatives Market

    11.1. Japan Blood Plasma Derivatives Market Overview

    11.2. Japan Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Blood Plasma Derivatives Market

    12.1. Australia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Blood Plasma Derivatives Market

    13.1. Indonesia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Blood Plasma Derivatives Market

    14.1. South Korea Blood Plasma Derivatives Market Overview

    14.2. South Korea Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Blood Plasma Derivatives Market

    15.1. Western Europe Blood Plasma Derivatives Market Overview

    15.2. Western Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Blood Plasma Derivatives Market

    16.1. UK Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Blood Plasma Derivatives Market

    17.1. Germany Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Blood Plasma Derivatives Market

    18.1. France Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Blood Plasma Derivatives Market

    19.1. Italy Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Blood Plasma Derivatives Market

    20.1. Spain Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Blood Plasma Derivatives Market

    21.1. Eastern Europe Blood Plasma Derivatives Market Overview

    21.2. Eastern Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Blood Plasma Derivatives Market

    22.1. Russia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Blood Plasma Derivatives Market

    23.1. North America Blood Plasma Derivatives Market Overview

    23.2. North America Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Blood Plasma Derivatives Market

    24.1. USA Blood Plasma Derivatives Market Overview

    24.2. USA Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Blood Plasma Derivatives Market

    25.1. Canada Blood Plasma Derivatives Market Overview

    25.2. Canada Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Blood Plasma Derivatives Market

    26.1. South America Blood Plasma Derivatives Market Overview

    26.2. South America Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Blood Plasma Derivatives Market

    27.1. Brazil Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Blood Plasma Derivatives Market

    28.1. Middle East Blood Plasma Derivatives Market Overview

    28.2. Middle East Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Blood Plasma Derivatives Market

    29.1. Africa Blood Plasma Derivatives Market Overview

    29.2. Africa Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Blood Plasma Derivatives Market Competitive Landscape And Company Profiles

    30.1. Blood Plasma Derivatives Market Competitive Landscape

    30.2. Blood Plasma Derivatives Market Company Profiles

    30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

    31. Blood Plasma Derivatives Market Other Major And Innovative Companies

    31.1. Meiji Group

    31.2. Grifols S.A.

    31.3. Shire Pharmaceuticals Inc.

    31.4. GC Biopharma Corp

    31.5. Emergent BioSolutions Inc.

    31.6. Shanghai Raas Blood Products Co Ltd.

    31.7. Kedrion S.p.A.

    31.8. Sanquin

    31.9. Biotest AG

    31.10. Bio Products Ltd.

    31.11. ADMA Biologics Inc.

    31.12. China Biologic Products Holdings Inc.

    31.13. BioIVT

    31.14. PlasmaGen BioSciences Pvt. Ltd.

    31.15. Virchow Biotech Private Limited

    32. Global Blood Plasma Derivatives Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Blood Plasma Derivatives Market

    34. Recent Developments In The Blood Plasma Derivatives Market

    35. Blood Plasma Derivatives Market High Potential Countries, Segments and Strategies

    35.1 Blood Plasma Derivatives Market In 2029 - Countries Offering Most New Opportunities

    35.2 Blood Plasma Derivatives Market In 2029 - Segments Offering Most New Opportunities

    35.3 Blood Plasma Derivatives Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Bayer AG Financial Performance
  • Table 81: Sanofi S.A. Financial Performance
  • Table 82: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 83: Baxter International Inc. Financial Performance
  • Table 84: CSL Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Bayer AG Financial Performance
  • Figure 81: Sanofi S.A. Financial Performance
  • Figure 82: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 83: Baxter International Inc. Financial Performance
  • Figure 84: CSL Limited Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Blood Plasma Derivatives market?

Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body. For further insights on the Blood Plasma Derivatives market, request a sample here

How will the Blood Plasma Derivatives market drivers and restraints affect the market dynamics? What forces will shape the Blood Plasma Derivatives industry going forward?

The Blood Plasma Derivatives market major growth driver - Surging Demand For Blood Plasma Derivatives Driven By The Increasing Prevalence Of Immune Deficiency Disorders. For further insights on the Blood Plasma Derivatives market, request a sample here

What is the forecast market size or the forecast market value of the Blood Plasma Derivatives market?

The Blood Plasma Derivatives market size has grown strongly in recent years. The blood plasma derivatives market size has grown strongly in recent years. It will grow from $51.81 billion in 2024 to $56.24 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $80.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation. For further insights on the Blood Plasma Derivatives market, request a sample here

How is the Blood Plasma Derivatives market segmented?

The blood plasma derivatives market covered in this report is segmented –
1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users Subsegments:
1) By Albumin: Human Serum Albumin, Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin
6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins For further insights on the Blood Plasma Derivatives market,
request a sample here

Which region has the largest share of the Blood Plasma Derivatives market? What are the other regions covered in the report?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Blood Plasma Derivatives market, request a sample here.

Who are the major players in the Blood Plasma Derivatives market?

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma . For further insights on the Blood Plasma Derivatives market, request a sample here.

What are the key trends in the Blood Plasma Derivatives market?

Major trends in the Blood Plasma Derivatives market include Strategic Partnerships In The Blood Plasma Derivatives Market For Enhancing Access And Supply For Immunoglobulins In France And Beyond. For further insights on the Blood Plasma Derivatives market, request a sample here.

What are the major opportunities in the Blood Plasma Derivatives market? What are the strategies for the Blood Plasma Derivatives market?

For detailed insights on the major opportunities and strategies in the Blood Plasma Derivatives market, request a sample here.

How does the Blood Plasma Derivatives market relate to the overall economy and other similar markets?

For detailed insights on Blood Plasma Derivatives's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Blood Plasma Derivatives industry?

For detailed insights on the mergers and acquisitions in the Blood Plasma Derivatives industry, request a sample here.

What are the key dynamics influencing the Blood Plasma Derivatives market growth? SWOT analysis of the Blood Plasma Derivatives market.

For detailed insights on the key dynamics influencing the Blood Plasma Derivatives market growth and SWOT analysis of the Blood Plasma Derivatives industry, request a sample here.